| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 04/24/1996 | EP0707846A2 A method for synthesizing a liposome |
| 04/24/1996 | EP0707489A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 04/24/1996 | EP0707476A1 Compounds for the photodecontamination of pathogens in blood |
| 04/24/1996 | EP0707471A1 Novel therapeutic drug delivery systems |
| 04/18/1996 | WO1996011021A2 Treatment of tissues to reduce subsequent response to injury |
| 04/18/1996 | CA2202272A1 Treatment of tissues to reduce subsequent response to injury |
| 04/17/1996 | EP0683665A4 Magnetically responsive composition for carrying biologically active substances and methods of production and use. |
| 04/11/1996 | WO1996010422A1 Conjugate for treating inflammatory diseases |
| 04/10/1996 | EP0705603A1 Use of non-toxic cysteine sulfoxide derivatives in the treatment of cancer or for enhancing the T-cell count |
| 04/10/1996 | EP0705098A1 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
| 04/09/1996 | US5506255 Organic pigments, fluorescent dyes |
| 04/04/1996 | WO1996008274A3 Conjugates of heparin-binding epidermal growth factor-like growth factor with targeted agents |
| 04/04/1996 | DE4435087A1 Konjugat zur Behandlung von Infektions-, Autoimmun- und Hauterkrankungen Conjugate for treatment of infectious and autoimmune diseases |
| 04/04/1996 | DE4434677A1 Ultra-pure water, free of tritium and carbon-14 |
| 04/02/1996 | US5504205 Reduced sp3 texaphyrins |
| 03/28/1996 | WO1996009315A1 Dna photocleavage using texaphyrins |
| 03/28/1996 | WO1996009071A1 Conjugate consisting of an active substance and a non-exogenous native protein |
| 03/28/1996 | WO1996009068A1 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases |
| 03/28/1996 | WO1996008965A1 Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers |
| 03/28/1996 | DE4433890A1 Konjugat aus einem Wirkstoff und einem nicht als körperfremd angesehenen, nativen Protein Conjugate of an active agent and a non-prestigious as foreign, native protein |
| 03/28/1996 | CA2200571A1 Dna photocleavage using texaphryns |
| 03/28/1996 | CA2199372A1 Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers |
| 03/27/1996 | EP0702719A1 Process for the sterilization of biological compositions and the product produced thereby |
| 03/27/1996 | EP0702685A1 Texaphyrin metal complex mediated ester hydrolysis |
| 03/21/1996 | WO1996008274A2 Conjugates of heparin-binding epidermal growth factor-like growth factor with targeted agents |
| 03/21/1996 | WO1996008234A1 Container with multi-phase composition for use in diagnostic and therapeutic applications |
| 03/20/1996 | EP0701695A1 Method and device for transmitting as a signal the biological activity of a carrier material to another carrier material, and for processing said signal, and product thereby obtained |
| 03/20/1996 | EP0701435A1 Compositions for boron neutron capture therapy and methods thereof |
| 03/14/1996 | WO1996007667A1 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids |
| 03/14/1996 | WO1996007432A1 Transfer of molecules into the cytosol of cells |
| 03/14/1996 | WO1996007431A1 Novel rhodamine derivatives for photodynamic therapy of cancer and in vitro purging of the leukemias |
| 03/14/1996 | WO1996007322A1 Method of sensitizing tumor cells with adenovirus e1a |
| 03/14/1996 | DE4432429A1 Pharmaceutical concentrates contg. lactic acid |
| 03/14/1996 | CA2199265A1 Method of sensitizing tumor cells with adenovirus e1a |
| 03/14/1996 | CA2197785A1 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids |
| 03/13/1996 | EP0700918A1 New iodized boron compounds useful as x ray contrasting agents, and pharmaceutical compositions containing them |
| 03/07/1996 | WO1996006641A1 Conjugates of vascular endothelial growth factor with targeted agents |
| 02/29/1996 | WO1996005862A1 Use of porphine cationic derivative salts as gram-negative bacteria photosensitizers |
| 02/28/1996 | EP0697876A1 Xenograft thymus |
| 02/28/1996 | EP0697875A1 Use of modified tall-104 cells to treat cancer and viral diseases |
| 02/27/1996 | US5494793 Covalently conjugated with physiological analyte; detectable markers fluorescent dyes or chromogens; elisa |
| 02/20/1996 | US5493017 Ring-metalated porphyrins |
| 02/20/1996 | US5492924 Phorbine derivatives and their use in the diagnosis and therapy of cancer |
| 02/20/1996 | US5492900 Method for enhancing the solubility of the boron delivery drug, boronophenylalanine (BPA) |
| 02/15/1996 | WO1996004340A1 Conducting electroactive biomaterials |
| 02/13/1996 | US5491219 Magnetic responsiveness |
| 02/08/1996 | WO1996003653A1 Superparamagnetic particles, process for their production and their use |
| 02/08/1996 | WO1996003147A1 Synthesis of chemical gels from polyelectrolyte polysaccharides by gamma-irradiation |
| 02/07/1996 | EP0420848B1 Carcinoma-associated antigens, and antibodies which recognize these antigens |
| 02/06/1996 | US5489590 Preactivating therpeutic compound |
| 02/01/1996 | WO1996002274A1 Conjugates made of metal complexes and oligonucleotides |
| 02/01/1996 | DE4427821A1 Stabilised super-paramagnetic aggregate particles |
| 02/01/1996 | CA2194558A1 Conjugates made of metal complexes and oligonucleotides |
| 01/23/1996 | US5486360 Method of treating tumour cells using catalase |
| 01/23/1996 | US5486274 Poly-substituted phthalocyanines |
| 01/17/1996 | EP0691841A1 Medicament dispensing stents |
| 01/16/1996 | US5484803 Transcutaneous in vivo activation of photosensitive agents in blood |
| 01/16/1996 | US5484778 Anticarcinogenic agents or antitumor agents |
| 01/09/1996 | US5482828 Synthetic media compositions and methods for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen |
| 01/09/1996 | US5482719 Drug delivery systems |
| 01/04/1996 | WO1996000113A1 Boron neutron capture enhancement of fast neutron therapy |
| 01/04/1996 | WO1996000090A1 Boron-containing hormone analogs and methods of their use in imaging or killing cells having hormone receptors |
| 01/04/1996 | CA2193974A1 Boron neutron capture enhancement of fast neutron therapy |
| 01/04/1996 | CA2170400A1 Boron-containing hormone analogs and methods of their use in imaging or killing cells having hormone receptors |
| 01/03/1996 | EP0689430A1 Superparamagnetic particles, process for producing the same and their use |
| 01/03/1996 | EP0316440B1 System and method for providing localized Mössbauer absorption in an organic medium |
| 12/19/1995 | CA1337754C Red-shifted phthalocyanine and tetrabenztriazaporphyrin reagents |
| 12/12/1995 | US5475104 Useful in magnetic resonance imaging; detection tumors, cancer cells; transition and lanthanide metals |
| 12/06/1995 | EP0684950A1 Chemical compounds useful in photodynamic therapy and production of laser light |
| 12/06/1995 | EP0398960B1 Transport of molecules across tissue using electroporation |
| 11/30/1995 | WO1995032206A1 Purpurin-18 anhydrides and imides as photosensitizers |
| 11/30/1995 | WO1995032001A1 Photodynamic conjugates with biocidal properties |
| 11/30/1995 | CA2191195A1 Photodynamic conjugates with biocidal properties |
| 11/29/1995 | EP0683671A1 Immune system modulation using psoralens activated with visible light |
| 11/29/1995 | EP0683665A1 Magnetically responsive composition for carrying biologically active substances and methods of production and use |
| 11/28/1995 | US5469854 Methods of preparing gas-filled liposomes |
| 11/28/1995 | CA1337651C Pheophorbide derivatives |
| 11/23/1995 | WO1995031429A1 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 11/22/1995 | EP0682517A1 Photodynamic treatment of synovium |
| 11/21/1995 | EP0691841A4 Medicament dispensing stents |
| 11/16/1995 | DE4416818A1 Micro:particles contg. gas and active agent |
| 11/09/1995 | WO1995029916A1 Electron-deficient porphyrins and processes and intermediates for preparing same |
| 11/09/1995 | WO1995029915A1 Polyethylene glycol derivatised dihydro or tetrahydro porphyrins, their preparation and their use as tumour localising, photosensitising compounds |
| 11/09/1995 | WO1995029702A1 Texaphyrin solid-supports and devices |
| 11/09/1995 | CA2189435A1 Polyethylene glycol derivatised dihydro or tetrahydro porphyrins, their preparation and their use as tumour localising, photosensitising compounds |
| 11/09/1995 | CA2187949A1 Electron-deficient porphyrins and processes and intermediates for preparing same |
| 11/08/1995 | EP0680365A1 Method of activating photosensitive agents |
| 11/08/1995 | EP0680363A1 Method and apparatus for providing light-activated therapy |
| 11/07/1995 | US5464013 Medical scanning and treatment system and method |
| 11/02/1995 | WO1995029180A1 Porphocyanine and cnc-expanded porphyrins |
| 10/31/1995 | US5462733 Immune system modulation using psoralens activated with visible light |
| 10/31/1995 | US5462724 Sensitizing agents for use in boron neutron capture therapy |
| 10/26/1995 | DE19512973A1 System for treating pain associated with cancer |
| 10/19/1995 | DE4412651A1 Compsn. for treating AIDS comprising inductively heatable particles |
| 10/17/1995 | US5459159 Anticarcinogenic/antitumor agents; allowing accumulation in abnormal cells, irradiation with light of specified wavelength |
| 10/17/1995 | US5459030 Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen |
| 10/17/1995 | US5458140 Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers |
| 10/12/1995 | WO1995026721A1 Inhibiting vascular smooth muscle cell proliferation |
| 10/12/1995 | WO1995026679A1 Therapeutic homeopathic dilutions of growth factors and methods of their use |
| 10/12/1995 | CA2186392A1 Therapeutic homeopathic dilutions of growth factors and methods of theiruse |